As of Jul 2, 2026, EHC's PEG ratio of 0.74 reflects its valuation relative to its growth. This value reflects a P/E ratio of 17.51 measured against EPS growth of 23.8%. When benchmarked against the trailing four-quarter average of 0.77, EHC's PEG ratio shows a 3.6% decrease.
Encompass Health's ten years historical PEG ratio averages out to 1.36. Compared to historical data, EHC's 0.74 PEG ratio represents a decrease of 46%. EHC reached its maximum PEG ratio of 5.91 during the Dec 2018 quarter over the past ten years. The Dec 2021 quarter had the bottom reading at 0.35, indicating the most optimal growth-adjusted valuation.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.78 | 18.89 | 24.1% |
| 2024 | 0.7 | 20.39 | 29.1% |
| 2023 | 0.66 | 19.01 | 29% |
| 2022 | N/A | 21.99 | -34.5% |
| 2021 | 0.35 | 15.73 | 44.6% |
| 2020 | N/A | 28.81 | -21.4% |
| 2019 | 0.84 | 18.98 | 22.5% |
| 2018 | 5.91 | 20.7 | 3.5% |
| 2017 | 4.29 | 17.16 | 4% |
| 2016 | 0.4 | 14.89 | 37.1% |
| 2015 | N/A | 17.23 | -17.9% |
| 2014 | N/A | 15.63 | -4.7% |
| 2013 | 0.24 | 12.91 | 54.5% |
| 2012 | N/A | 12.64 | -12.6% |
| 2011 | N/A | 9.25 | -79.7% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.67 | 15.91 | 23.8% |
| Dec 2025 | 0.78 | 18.89 | 24.1% |
| Sep 2025 | 0.85 | 23.65 | 27.9% |
| Jun 2025 | 0.77 | 23.63 | 30.7% |
| Mar 2025 | 0.67 | 20.63 | 30.9% |
| Dec 2024 | 0.7 | 20.39 | 29.1% |
| Sep 2024 | 1.24 | 23.01 | 18.6% |
| Jun 2024 | 0.82 | 21.61 | 26.4% |
| Mar 2024 | 0.58 | 22.02 | 37.9% |
| Dec 2023 | 0.66 | 19.01 | 29% |
| Sep 2023 | 0.66 | 18.97 | 28.7% |
| Jun 2023 | N/A | 21.56 | -4.8% |
| Mar 2023 | N/A | 19.89 | -31.1% |
| Dec 2022 | N/A | 21.99 | -34.5% |
| Sep 2022 | N/A | 16.45 | -32.6% |
EHC's PEG ratio today is above its 5-year average, yet it comes in under the 3 and 10-year averages.
With a PEG of 0.74, EHC stands above the Healthcare sector average. In comparison with its Healthcare sector average of 0.6, Encompass Health's PEG is 23% higher.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| EHC Encompass Health Corp | 0.74 | $10.56B |
| NUTX Nutex Health Inc | N/A | $1.35B |
Based on Jul 2, 2026 data, EHC shows a PEG ratio of 0.74.
EHC's 3-year PEG ratio average comes in at 0.76.
EHC's 5-year PEG ratio average comes in at 0.7.
In the last ten years, EHC's peak PEG ratio of 5.91 was recorded in the Dec 2018 quarter.
Currently, EHC's PEG ratio is 46% lower than its 10-year historical average.
The PEG ratio comes from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Jul 2, 2026, Encompass Health carries a P/E ratio of 17.51. Earnings grew at 23.8% over the TTM period ending Mar 2026. Applying the formula, this yields a price to earnings growth ratio of 0.74. PEG RATIO(0.74) = PE RATIO(17.51) / EPS GROWTH(23.8%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.